Amylyx Pharmaceuticals stockAMLX
Amylyx Pharmaceuticals trades at $27.62, 32.9% below its 52-week high (Aug 21, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +128.6% year to date, +108.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for AMLX — after you log in
Open the terminalFrequently asked questions about Amylyx Pharmaceuticals
What is the Amylyx Pharmaceuticals stock price?
At the close on Nov 5, 2026: $27.62 (−6.05% on the day). 52-week high: $41.14 on Aug 21, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Amylyx Pharmaceuticals report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed −3% year over year, revenue 0%.
Does Amylyx Pharmaceuticals pay dividends?
No, Amylyx Pharmaceuticals does not pay dividends.
Where does Amylyx Pharmaceuticals trade and how to buy it?
Ticker AMLX, exchange Nasdaq, listed since 2022. You can buy it through a broker with access to US exchanges.
Should I buy Amylyx Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for AMLX are in the terminal after you log in.